243 results on '"Nout, Remi A"'
Search Results
2. Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials
3. Time-action and patient experience analyses of locally advanced cervical cancer brachytherapy
4. Survival of Women with Advanced Stage Cervical Cancer: Neo-Adjuvant Chemotherapy Followed by Radiotherapy and Hyperthermia versus Chemoradiotherapy
5. Multibody dynamic modeling of the behavior of flexible instruments used in cervical cancer brachytherapy
6. Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation
7. HECTOR: multimodal deep learning predicts recurrence risk in endometrial cancer.
8. SO019LBA/#875 Molecular features predicts outcomes in multicentric international study of chemoradiation and MRI based image guided brachytherapy for cervical cancer (EMBRACE): final analysis from bioembrace-I
9. SO006/#55 Regular dilation and/or sexual activity show less risk for vaginal stenosis in cervical cancer patients
10. Predictive Factors for Toxicity After Primary Chemoradiation for Locally Advanced Cervical Cancer: A Systematic Review
11. Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, -2 and -3 trials
12. Co-occurrence of symptoms after radiochemotherapy in locally advanced cervix cancer patients: a cluster analysis
13. Clinical Behavior and Molecular Landscape of Stage I p53-abnormal Low-Grade Endometrioid Endometrial Carcinomas
14. 127 Impact of Brachytherapy Applicator on Clinical Outcomes in Cervix Cancer: An EMBRACE-I Study Analysis
15. EviGUIDE - a tool for evidence-based decision making in image-guided adaptive brachytherapy for cervical cancer
16. Early and late contrast enhancing lesions after photon radiotherapy for IDH mutated grade 2 diffuse glioma
17. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023
18. The impact of bone marrow sparing on organs at risk dose for cervical cancer: a Pareto front analysis
19. HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trial
20. ESGO/ESTRO quality indicators for radiation therapy of cervical cancer
21. ESGO/ESTRO quality indicators for radiation therapy of cervical cancer
22. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*
23. ESTRO/ESGO/SIOPe guidelines for the management of patients with vaginal cancer
24. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*
25. Tools for large-scale data analytics of an international multi-center study in radiation oncology for cervical cancer
26. Abstract 5695: Deep learning risk prediction model of distant recurrence from H&E endometrial cancer slides
27. Data from Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer
28. Data from Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer
29. Supplementary Data from Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer
30. Supplementary Data from Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer
31. Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors
32. Supplementary figure 6 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
33. Supplementary Table S2 from Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas
34. Table S3 from Adjuvant Treatment for POLE Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues
35. Supplementary figure 1 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
36. Supplementary Table S5 from Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts
37. Table S5 from Adjuvant Treatment for POLE Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues
38. Figure S1 from Adjuvant Treatment for POLE Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues
39. Supplementary figure 4 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
40. Figure S2 from Adjuvant Treatment for POLE Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues
41. Supplementary table 2 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
42. Supplementary Figure S2 from Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas
43. Figure S4 from Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma
44. Supplementary Figure S2 from Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas
45. Figure S2 from Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma
46. Figure S7 from Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma
47. Figure S3 from Adjuvant Treatment for POLE Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues
48. Table S1 from Adjuvant Treatment for POLE Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues
49. Table S4 from Adjuvant Treatment for POLE Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues
50. Table S2 from Adjuvant Treatment for POLE Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.